CD4 and tuberculosis: This seemed to be a valid approach since MHC-II-bound peptides drive CD4-dependent anti-tuberculosis TH1 response, and CD4 T cell deficient human HIV-1 infected patients rapidly succumb due to tuberculosis [59].